NCT02080221View on ClinicalTrials.gov

BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

January 9, 2020

Study Completion Date

March 16, 2022

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG

FOLFOXA

Trial Locations (2)

02179

Southcoast centers for cancer care, Fairhaven

02903

Lifespan Hospitals (The Miriam and RI Hospital, East Greenwich, Newport), Providence

Sponsors

Lead Sponsor

Brown University

All Listed Sponsors

collaborator

Lifespan

OTHER

collaborator

SouthCoast Medical Group

OTHER

collaborator

Memorial hospital

UNKNOWN

lead

Brown University

OTHER